Bullboard - Stock Discussion Forum DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s): DHTRF

Healthcare

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

Add To Watchlist

TSX:DHT.UN - Post Discussion

DRI Healthcare Trust > DRI Healthcare Trust Acquisition of a Royalty Interest

View:

Post by Betteryear2 on Jun 30, 2023 7:41am

DRI Healthcare Trust Acquisition of a Royalty Interest

– Patent-protected exclusivity and uncapped deal structure offers attractive return profile –

– Acquisition generates substantial near-term cash flows and long-term portfolio growth –

– DRI Healthcare expects flat to slightly growing cash receipts through 2030 –

TORONTO, June 30, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has purchased a royalty interest in the worldwide net sales of Orserdu™ from Eisai Co., Ltd. ("Eisai") for US$85 million. This transaction brings DRI Healthcare's total deployments since its IPO in February 2021 to US$570 million, with an additional US$55 million in potential milestones and options.

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Net Sales of Orserdu™ (elacestrant) and Reiterates Long-Term Cash Receipts Outlook (newswire.ca)